Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
FR

Frederic Ran — 7 Patents

Hoffmann-La Roche: 3 patents #991 of 3,238Top 35%
FPFedora Pharmaceuticals: 2 patents #5 of 9Top 60%
MCMeiji Seika Pharma Co.: 2 patents #74 of 183Top 45%
FAF. Hoffmann-La Roche Ag: 1 patents #201 of 425Top 50%
Kembs, FR: #5 of 21 inventorsTop 25%
Overall (All Time): #680,018 of 4,157,543Top 20%
7 Patents All Time
Frederic Ran has been granted 7 US patents while listed as an inventor at Hoffmann-La Roche. The first was granted in 2008 and the most recent in November 2025. Frederic Ran ranks #680,018 of 4,157,543 US inventors in our database (top 16.4%). Patent records list Frederic Ran in Kembs, FR.

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
12459947 Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crystalline forms thereof Benno Rothenhaeusler, Rene Trussardi, Fabienne Hoffmann-Emery, Urs Schwitter, Jean-Michel Adam +5 more 2025-11-04
11040977 Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crytalline forms thereof Benno Rothenhaeusler, Rene Trussardi, Fabienne Hoffmann-Emery, Urs Schwitter, Jean-Michel Adam +5 more 2021-06-22
10919041 Preparing and analyzing solid form properties of a substance Urs Schwitter, André Marcel ALKER, Tom Kissling, Thomas Zumstein 2021-02-16
10759800 Crystalline forms of diazabicyclooctane derivatives and production process thereof Michael Kammerer 2020-09-01
10584123 Pharmaceutical forms of diazabicyclooctane derivatives and manufacturing method thereof Michael Kammerer 2020-03-10
10246460 Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[E]azulene and crytalline forms thereof Benno Rothenhaeusler, Rene Trussardi, Fabienne Hoffmann-Emery, Urs Schwitter, Jean-Michel Adam +5 more 2019-04-02
7438861 Heatable pipette Remo Anton Hochstrasser, Dieter Voegelin 2008-10-21